Forkhead Box q1 promotes invasion and metastasis in colorectal cancer by activating the epidermal growth factor receptor pathway

doi:10.3748/wjg.v28.i17.1781

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 28, Issue 17

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4817)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series, Tables (1-4) series.

Item

Count

PDF

282

WORD

121

HTML

2448

Figures (1-6)

406

Tables (1-4)

312

Sum=3569

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

366

Download

882

Sum=1248

May 7, 2022 (publication date) through Nov 11, 2024

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastroenterol. May 7, 2022; 28(17): 1781-1797
Published online May 7, 2022. doi: 10.3748/wjg.v28.i17.1781

Table 4 Correlation analysis of forkhead Box q1 and heparin binding epidermal growth factor expression in cohort (n = 65) colorectal cancer tissues

		FOXQ1, negative (n = 31)	FOXQ1, positive (n = 34)	χ²	P value
HB-EGF	Negative (n = 26)	20	6	4.116	< 0.05
HB-EGF	Positive (n = 39)	11	28	4.116	< 0.05

FOXQ1: Forkhead Box q1; HB-EGF: Heparin binding epidermal growth factor.

Citation: Zhang JJ, Cao CX, Wan LL, Zhang W, Liu ZJ, Wang JL, Guo Q, Tang H. Forkhead Box q1 promotes invasion and metastasis in colorectal cancer by activating the epidermal growth factor receptor pathway. World J Gastroenterol 2022; 28(17): 1781-1797
URL: https://www.wjgnet.com/1007-9327/full/v28/i17/1781.htm
DOI: https://dx.doi.org/10.3748/wjg.v28.i17.1781